Quantitative MRI assessment of a novel direction modulated brachytherapy tandem applicator for cervical cancer at 1.5T.

CONCLUSIONS: This work demonstrated that the novel DMBT tandem applicator prototype has minimal artifact in T2-weighted images employed in clinical practice, suggesting the applicator might be a good candidate for MRI-guided adaptive brachytherapy. PMID: 27443448 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27443448?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 17, 2016 Category: Radiology Authors: Soliman AS, Elzibak A, Easton H, Kim JY, Han DY, Safigholi H, Mashouf S, Owrangi A, Ravi A, Song WY Tags: Radiother Oncol Source Type: research